TIDMXCT

RNS Number : 1334P

XCounter AB

29 September 2011

PRESS RELEASE

Stockholm, 29 September 2011

XCounter delivers 1(st) prototype of the new photon counting detector to Artemis Imaging GbmH

XCounter AB (AIM: XCT) ("XCounter" or the "Company"), a technology leader in the development and supply of specialty X-ray detectors, announces the delivery of its first detector prototype based on the Company's state of the art photon counting technology (PCT) to its customer Artemis Imaging GmbH ("Artemis"). This delivery forms part of the ongoing development collaboration in which Artemis is developing an innovative 3-D mammography CT system.

The new breast imaging system will incorporate XCounter's innovative digital photon counting solid state detector platform, which enables fast, high quality 3-D imaging with the lowest possible radiation dose.

Under the collaboration agreement, the commencement of which was announced in December 2010, Artemis is funding XCounter's Mammo-CT detector development including delivery of a fully functioning detector prototype.

For further information, please contact:

XCounter AB Tel: +46 (0) 8 622 23 00 Mikael Strindlund, CEO

Nomura Code Securities Tel: +44 (0) 20 7776 1200 Phil Walker/Clare Terlouw

Capital MS&L Tel: +44 (0) 207 307 5330 Anna Davies

About XCounter AB XCounter AB is a leader in the development and supply of direct conversion, photon counting and tomosynthesis based 3D X-ray imaging technologies for medical, dental and industrial X-ray imaging.

Headquartered in Stockholm, XCounter employs 28 people in its facilities in Sweden and Finland. For more detailed information, please visit: www.xcounter.se

This information is provided by RNS

The company news service from the London Stock Exchange

END

STREVLFLFKFXBBV

Xcounter (LSE:XCT)
Historical Stock Chart
Von Mai 2024 bis Jun 2024 Click Here for more Xcounter Charts.
Xcounter (LSE:XCT)
Historical Stock Chart
Von Jun 2023 bis Jun 2024 Click Here for more Xcounter Charts.